Effect of tissue microenvironment on fibrous capsule formation to biomaterial-coated implants.

"Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dr. Jensen has received payments for consulting from Abbvie, Cooper Surgical, Bayer Healthcare, Evofem, Mayne Pharma, Merck, Sebela, and TherapeuticsMD. OHSU has received research support from 10.13039/100006483Abbvie, Bayer Healthcare, Daré, Estetra SPRL, Medicines360, 10.13039/100004334Merck, and Sebela. These companies and organizations may have a commercial or financial interest in the results of this research and technology. These potential conflicts of interest have been reviewed and managed by OHSU. Bob Katz is a paid consultant for Sebela Pharmaceuticals and CEO of Hybridge Medical, LLC."

"We thank I. Suydam for his help with TLC and the method for PD detection. We also thank A. Roehrich for her assistance with ICP-OES and acknowledge the Spectroscopic and Analytical Instrumentation Facility at the University of Washington. Research is supported by the 10.13039/100000865Bill and Melinda Gates Foundation grant to the Oregon Permanent Contraception Research Center [OPP1006248 to JTJ and KAW]; 10.13039/100000002NIH/10.13039/100000060NIAID [R01-AI-150325 to KAW and JTJ]; 10.13039/100008227ARCS (Achievement Rewards for College Scientists) foundation [to JH]; and the Howard Hughes Medical Institute (10.13039/100000011HHMI) [Gilliam Fellowship for Advanced Study to JH and KAW]."